The table below shows REGENERON PHARMACEUTICALS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q3 2026
Q2 2026
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Revenue
$5.12B
$4.29B
$3.61B
$3.75B
$3.68B
$3.03B
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$1.79B
$1.63B
$1.54B
$1.48B
$1.42B
$1.33B
REGN annual revenue (10-K history)
REGENERON PHARMACEUTICALS, INC. reported annual revenue of $14.34B for fiscal year 2025. That is up 1.0% from $14.20B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $4.86B (FY 2016) to $14.34B. Figures come from the company's audited annual reports as filed with the SEC.
